First National Trust’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.32M Buy
92,160
+13,291
+17% +$335K 0.08% 159
2026
Q1
$1.99M Buy
78,869
+35,830
+83% +$914K 0.07% 187
2025
Q4
$1.1M Buy
43,039
+25,167
+141% +$644K 0.04% 238
2025
Q3
$458K Buy
17,872
+4,312
+32% +$109K 0.02% 300
2025
Q2
$343K Buy
13,560
+407
+3% +$10.1K 0.01% 318
2025
Q1
$329K Buy
13,153
+3,040
+30% +$75.2K 0.01% 314
2024
Q4
$249K Buy
+10,113
New +$253K 0.01% 354

Other funds holding IBDX

First National Trust's IBDX Position: Q2 2026 in Review

First National Trust increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 17% in Q2 2026, buying an estimated $335K and bringing the position to 92,160 shares worth $2.32M. The position accounts for 0.08% of the portfolio, ranked #159.

First National Trust first reported a position in IBDX in Q4 2024 and has held it in 7 quarters since. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • First National Trust held 92,160 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $2.32M as of Q2 2026.
  • First National Trust bought 13,291 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $335K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.08% of First National Trust's portfolio in Q2 2026, its #159 holding.
  • First National Trust first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2024 and has held it in 7 quarters since.
  • 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on First National Trust's 13F filing for Q2 2026, filed 30 Jul 2026.